Ernexa Therapeutics Inc.
ERNA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000748592
No open-market purchases or sales by Ernexa Therapeutics Inc. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $236.2K in total; no superinvestor holds it.
Other share classesERNAW
Holders of 5% or more of ERNA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Ernexa Therapeutics Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Cherington Charles | 13D/A | 34.70%10.8M shares | −3.20 ppfrom 37.90% | May 13, 20219 filings | Feb 17, 2026 | SEC |
| Freebird Partners LP | 13G/A | 9.90%6.21M shares | −0.09 ppfrom 9.99% | Dec 2, 20225 filings | May 14, 2025 | SEC |
| Freebird Partners LP | 13G/A | 9.90%786.0K shares | – | Dec 19, 20251 filing | Dec 19, 2025 | SEC |
| Freebird Partners LP | 13G/A | 9.90%120.4K shares | – | May 15, 20261 filing | May 15, 2026 | SEC |
| Konar Shameek | 13G/A | 9.70%118.3K shares | +4.20 ppfrom 5.50% | May 15, 20252 filings | May 13, 2026 | SEC |
| Konar Shameek | 13G/A | 7.12%558.5K shares | – | Dec 16, 20251 filing | Dec 16, 2025 | SEC |
| Bleichroeder LP | 13G | 6.86%80.0K shares | New | May 14, 20261 filing | May 14, 2026 | SEC |
| Halpern John D | 13G/A | 5.60%66.8K shares | −4.00 ppfrom 9.60% | May 24, 20217 filings | May 15, 2026 | SEC |
| Iaf, LLC | 13G/A | 5.20%3.26M shares | −0.02 ppfrom 5.22% | Dec 20, 20233 filings | May 14, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
53 Schedule 13D and 13G filings on Ernexa Therapeutics Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 16, 2021 | Gentile Guy | 13GOld format | – | New | – | SEC |
| Feb 12, 2021 | Bard Associates Inc | 13G/AOld format | – | – | – | SEC |
| Jan 29, 20214:25 PM ET | Ault Global Holdings, Inc. | 13DOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Ernexa Therapeutics Inc. shares.
No Form 144 notices for Ernexa Therapeutics Inc. are on file.